The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 61 | — | 20.1x | Near average | |
Growth | 80 | 100.0% | 5.6% | Above average | |
Quality | 52 | 178.8% | 7.6% | Near average | |
Safety | 55 | 1.3x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 69 | — | — | Above average | |
Sentiment | 78 | — | — | Above average |
Palvella Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Palvella Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
PVLA stock saw stability in the average target price at 205.15 dollars despite one analyst recently exiting coverage, reducing the number of analysts from 6 to 5. The data reflects cautious optimism; the consensus rose slightly (0.6%) over the past 30 days, with a wide price gap (Dispersion) between the low of 143 dollars and the high of 255 dollars, indicating a variance in estimating the speed of expected future revenue growth.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.